Biologische Hochschulschriften (Goethe-Universität)
Refine
Year of publication
Document Type
- Doctoral Thesis (847)
- Article (12)
- Part of Periodical (2)
- Bachelor Thesis (1)
- Diploma Thesis (1)
Has Fulltext
- yes (863)
Is part of the Bibliography
- no (863)
Keywords
- Gentherapie (7)
- NMR-Spektroskopie (6)
- gene therapy (6)
- Elektrophysiologie (5)
- Molekularbiologie (5)
- RNA (5)
- Schmerz (5)
- Apoptosis (4)
- Arzneimitteldesign (4)
- Carotinoide (4)
Institute
- Biowissenschaften (547)
- Biochemie und Chemie (169)
- Biochemie, Chemie und Pharmazie (78)
- Pharmazie (32)
- Institut für Ökologie, Evolution und Diversität (20)
- Georg-Speyer-Haus (6)
- Medizin (5)
- Geowissenschaften (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (3)
- Frankfurt Institute for Advanced Studies (FIAS) (3)
Generally speaking, protein import into mitochondria and chloroplasts is a post-translational process during which the precursor proteins destined for mitochondria or chloroplasts are translated with cytosolic ribosomes and targeted. The previous results showed that the isolated chloroplasts can import in vitro synthesized proteins and the absence of ribosomes in the immediate area around chloroplasts in electron microscopy (EM) images. However, none of the EM images were recorded in the presence of a translation elongation inhibitor. Also, the observation showed that ribosomes stably bind to purified liver mitochondria in vitro, and the first indication of chloroplast localization of mRNAs encoding plastid proteins in Chlamydomonas rheinhardtii, which challenge the post-translational import and support the co-translational process. Therefore, in this study, the association of the ribosomes to the isolated chloroplasts were analyzed, a binding assay was established and showed that naked ribosomes are not considerably bound to chloroplasts. Additionally, mRNA localize in close vicinity to mitochondria also challenged post-translation protein import. Global analysis of transcripts bound to mitochondria in yeast or human revealed that around half of the transcripts of mitochondrial proteins displayed a high mitochondrial localization. The observed association of mRNAs with chloroplast fractions and the in vivo analysis of the distribution of mRNAs was used as base to formulate the hypothesis that mRNA can bind to chloroplast surface. Therefore, in this study, the mRNA binding assay was established and revealed that mRNAs coding for the mitochondrial cytochrome c oxidase copper chaperone COX17 showed unspecific binding to the chloroplasts. The mRNA coding for chloroplast outer envelope transport protein OEP24 and mRNA coding for the essential nuclear protein 1 (ENP1) showed specific binding, and OEP24 has a 3-fold higher affinity than ENP1 mRNA. Moreover, the BY2-L (Nicotiana tabacum non-green cell culture) could confer the highest enhancement of OEP24 mRNA binding efficiency than the COX17 and ENP1 mRNA and the preparation of the BY2-L was optimized. Afterwards, the feasibility to fix the interaction between mRNA and the proteins on the surface of chloroplasts was confirmed. OEP24 mRNA showed more efficiency in the UV-crosslinking. Following, the pull-down with antisense locked nucleic acid (LNA)/DNA oligonucleotides was established which could be used for the further investigation of the proteins involved in the mRNA binding to the chloroplasts.
Plastic pollution is a pervasive problem. In the environment, both the physical and chemical aspects of the material contribute to pollution. For instance, discarded plastic is useless waste that is fragmented upon degradation and so-called microplastics <5 mm are formed. Besides, the chemicals added into plastics are usually customized for specific functions, but these can easily transfer from the polymer into an ambient medium. This work examined both of these aspects. Moreover, the question of whether ecotoxicological effects are more likely to appear because of the microparticle properties or the chemicals transferring from the microplastics was addressed. A special focus was laid on the UV-weathering-induced chemical release.
First, conventional and biodegradable plastics made from fossil and bio-based resources were chosen. The different materials (pre-production and recycled pellets as well as final products)were weathered and their leachates evaluated in vitro. The leachates were analyzed with nontarget screening in order to measure the number of transferred chemicals. Plastics identified as toxic were subjected to further investigations in vivo. A biodegradable shampoo bottle was processed to microplastics and the particles’ physical and chemical properties were assessed with the freshwater worm Lumbriculus variegatus. Here, commonly used endpoints such as mortality, reproduction and weight were tested via different exposure routes. Moreover, the freshwater shrimp Neocaridina palmata was exposed to microplastic beads and fragments to clarify if the shape of the particles affects the ingestion and egestion, respectively. Thereafter, two materials that displayed the strongest toxic responses in vitro within the first study were weathered and leached. Finally, the shrimps were exposed to the leachates and the locomotor behavior was used as an ecologically relevant but less frequently studied endpoint.
The results of the studies highlight that plastics are chemically complex mixtures, containing a wide range of chemicals in terms of the number and functionality. These chemicals induced oxidative stress, baseline toxicity and endocrine activities. This shows that pellets represent a processing state that comprises chemically heterogenous materials. Moreover, it was shown that a degradation initiator is not necessarily relevant to trigger inherent substances to leach out from plastics. Despite this, the UV-weathering resulted in increasingly released chemicals and exacerbated the in vitro toxicities. Even plastics assessed as toxicologically harmless prior to weathering released toxic chemical mixtures once they were weathered. One recycled and all of the biodegradable plastics were toxicologically most concerning. This means that such materials are currently not better than conventional, virgin plastics in terms of their toxicity.
To clarify the source of the microplastic toxicity, L. variegatus was exposed to biodegradable microplastics. The particles were ingested by the worms and adversely affected the examined endpoints. In comparison, microplastics that were depleted from their chemicals via a solvent treatment were less toxic. Kaolin as a natural particle control was evaluated alongside and positively affected the weight of the worms. This emphasizes the ecological relevance of fine-sized matter for the test species. The chemicals extracted from the microplastics induced a 100% mortality. A chemical analysis of the material revealed two ecotoxicologically relevant biocides. The physically-mediated effects of the microplastics seemed to be less of a concern for the worms, which is probably linked to their adaptation to high concentrations of naturally occurring particles in the environment. However, the effects related to the chemicals of plastic cannot be ignored, especially for materials that are claimed to be environmentally friendly.
In the third study, the role of the particle shape in the gut passaging of N. palmata was studied. While the particle size was a determinant factor for the ingestion, the ingestion and egestion of the beads and fragments did not differ, respectively. The shrimps ingested less fragments when food was provided than in the absence of food. As for the worms, the shrimps are known to ingest many naturally occurring particles. Their unselective feeding behavior towards the particle shape could indicate that microplastics as a physical pollutant are negligible for the shrimps. That is why the chemicals of the two most toxic in vitro materials were tested with N. palmata. However, no trend towards elevated or reduced movements of the shrimps was observed, even though the leachates contained baseline toxicants. This shows that the in vitro toxicities of plastics are not necessarily indicative for effects to occur at the in vivo level...
Until quite recently, stem cell technology mainly focused on pure populations of embryonic stem cells (ES) derived from the inner cell mass of the blastocyst and induced pluripotent stem cells (iPS). Using organoids, a newly established culture technique, it is now possible to culture also organ and patient-specific adult stem (AS) and induced pluripotent stem (IPS) cells in vitro. Furthermore, it has been shown that adult stem cells, grown as organoids, are genetically stable, proliferate and maintain their multi-potency (often a bi-potency) for months. This is possible by providing conditions that recapitulate the stem cell niche of the corresponding organ. Particularly, defined growth factors and a physiological scaffold, which is provided by an extracellular matrix (ECM). Because of increasing research activities, organoids became influential in the recent years. Wide-ranging interest also led to a clearer definition: organoids must contain multiple organ-specific cell types, must be able to recapitulate some organ specific functions, and the cells must be spatially organized in a way similar to the organ they are derived from. The excitement about organoids is based on their high potential as a model to understand wound healing, cellular behaviour and differentiation processes in organogenesis. Furthermore, high potential in the drug development and in personalized stem cell therapeutic approaches has been shown. Specifically, for personalized stem cell therapy, one potential application is for chronic autoimmune diseases such as Diabetes type 1 (T1D). T1D is characterized by the immune-mediated destruction of ß-cells in the Pancreas that leads to absolute insulin deficiency. In T1D the first-line therapeutic approach is exogenous insulin replacement therapy, which always implicates the risk of high fluctuations in blood-sugar levels and therefore the risk of hypoglycaemia. Another therapeutic approach is the xenotransplantation of islets from human donors. A successful islet transplantation allows patients a years-long insulin independence. However, the therapeutic value of islet transplantation is highly limited by the availability of organ donors and by the need for chronic administration of immune suppressive medication. The use of pancreas organoids offers a promising alternative as a personalized cell therapeutic approach to treat T1D without the hypoglycaemia risks of the established therapies. In 2013 Meritxell Huch and colleagues established for the first-time organoids from the exocrine, ductal part of the pancreas. These pancreas organoids are characterized by a monolayered, spherical cell epithelium which comprises a liquid filled lumen. In addition, they showed that after transplantation of these cells into immunodeficient mice, they differentiate into ß-cells and cure T1D. However, basic knowledge of the culture growth behaviour is still lacking: to date, no growth parameters are defined and reliable and robust investigation approaches are still missing. Furthermore, basic knowledge about the organoid development and biochemical/biophysical mechanisms that generate the phenotypic structure are not identified. For a clinical approach these parameters are fundamental and therefore must be defined pre-clinically.
The aim of this study is the preclinical characterization of the hPOs...
Interleukin-11 signaling is a global molecular switch between regeneration and scarring in zebrafish
(2022)
The two diametrically opposing outcomes after tissue damage are regeneration and fibrotic scarring. After injury, adult mammals predominantly induce fibrotic scarring, which most often leads to patient lethality. Fibrotic scarring is the deposition of excessive extracellular matrix that matures and hinders tissue function. The scarring response is mainly orchestrated by myofibroblasts, which arise only upon tissue damage, from various cellular origins, including tissue resident fibroblasts, endothelial cells and circulating blood cells. On the contrary, species like zebrafish, possess the remarkable capacity to regenerate their damaged tissues. After injury, instead of inducing a myofibroblast-mediated fibrogenic gene program, cells in these species undergo regenerative reprogramming at the transcriptional level to activate vital cellular processes needed for regeneration, including proliferation, dedifferentiation, and migration. Several pro-regenerative mechanisms have been identified to date. Most of them, if not all, are also important for tissue homeostasis and hence, are not injury specific. Therefore, the central aim of this study is to identify injury-specific mechanisms that not only induce regeneration, but also limit fibrotic scarring.
To test the notion that fibrotic scarring limits regeneration, I first compared the scarring response in the regenerative zebrafish heart after cryoinjury with what is known in the non-regenerative adult mouse heart. I found that zebrafish display ~10-fold less myofibroblast differentiation compared to adult mouse after cardiac injury. With these findings, I hypothesized that zebrafish employ mechanisms to actively suppress scarring response. Using a novel comparative transcriptomic approach coupled with genetic loss-of-function analyses, I identified that Interleukin-6 (Il-6) cytokine family-mediated Stat3 is one such pro-regenerative pathway in zebrafish.
Il-6 cytokine family consists of Il-6, Interleukin-11 (Il-11), Ciliary neurotrophic factor, Leukemia inhibitory factor, Oncostatin M, and Cardiotrophin-like cytokine factor 1. Il-6 family ligands signal through their specific receptors and a common receptor subunit (Il6st or Gp130). Using gene expression analyses after adult heart and adult caudal fin injuries in zebrafish, I identified that both the Il-11 cytokine encoding paralogous genes (il11a and il11b) are the highest expressed and induced among the Il-6 family cytokines. Hence, I chose Il-11 signaling as a candidate pathway for further analysis. To investigate the role of Il-11 signaling, I generated genetic loss-of-function mutants for both the ligand (il11a and il11b) and the receptor (il11ra) encoding genes. Using various tissue regeneration models across developmental stages in these mutants, I identified that Il-11/Stat3 signaling is indispensable for global tissue regeneration in zebrafish.
To investigate the cellular and molecular mechanisms by which Il-11 signaling promotes regeneration, I performed transcriptomics comparing the non-regenerative il11ra mutant hearts and fins with that of the wild types, respectively. I identified that Il-11 signaling orchestrates both global and tissue-specific aspects of regenerative reprogramming at the transcriptional level. In addition, I also found that impaired regenerative reprogramming in the il11ra mutant hearts and fins resulted in defective cardiomyocyte and osteoblast repopulation of the injured area, respectively.
On the other hand, by deep phenotyping the scarring response in il11ra mutant hearts and fins, I identified that Il-11 signaling limits myofibroblast differentiation. Furthermore, I found that cardiac endothelial cells and fibroblasts are one of the major responders to injury-induced Il-11 signaling. Using lineage tracing, I found that both the endothelial and fibroblast lineages in the non-regenerative il11ra mutants commit to a myofibroblast fate, spearheading the scarring response. In addition, using cell type specific manipulations, I showed that Il-11 signaling in cardiac endothelial cells allows cardiomyocyte repopulation of the injured area. Finally, using human endothelial cells in culture, I uncovered a novel feedback mechanism by which Il-11 signaling limits fibrogenic gene expression by inhibiting its parent activator and a master regulator of tissue fibrosis, TGF-β signaling.
Overall, I identified Interleukin-11/Stat3 signaling as the first global regulator of regeneration in zebrafish. Briefly, I showed that Interleukin-11 signaling promotes regeneration by regulating two crucial cellular aspects in response to injury – (1) it promotes regenerative reprogramming, thereby allowing cell repopulation of the injured area and (2) it limits mammalian-like fibrotic scarring by inhibiting myofibroblast differentiation and TGF-β signaling. Altogether, these zebrafish data, together with the contradicting mammalian data strongly indicate that the secrets of tissue regeneration lie downstream of IL-11 signaling, in the differences between regenerative and non-regenerative species. Furthermore, I establish the non-regenerative il11ra mutant as an invaluable zebrafish model to study mammalian tissue fibrosis.
The heart is the first functional organ that develops in the embryo. To become a functional organ, it undergoes several morphogenetic processes. These morphogenetic events involve different cell types, that interact with each other and respond to the surrounding extracellular matrix, as well as intrinsic and extrinsic mechanical forces, assuming different behaviors. Additionally, transcription factor networks, conserved among vertebrates, control the development.
To have a better understanding of cell behavior during development, it is necessary to find a model system that allows the investigation in vivo and at single-cell resolution. Thanks to the common evolutionary origin of the different cardiac structures, together with the conserved molecular pathways, the two-chambered zebrafish heart offers many advantages to study cell behavior during cardiac morphogenesis. Here, using the zebrafish heart as a model system, I uncovered the cell behavior behind two of the main cardiac morphogenetic events: cardiac wall maturation and cardiac valve formation.
In the first part of this study, I investigated how the cardiac wall is maintained at the molecular level. Using genetic, transcriptomic, and chimeric analyses in zebrafish, we find that Snai1b is required for myocardial wall integrity. Global loss of snai1b leads to the extrusion of CMs away from the cardiac lumen, a process we show is dependent on cardiac contractility. Examining CM junctions in snai1b mutants, we observed that N-cadherin localization was compromised, thereby likely weakening cell-cell adhesion. In addition, extruding CMs exhibit increased actomyosin contractility basally, as revealed by the specific enrichment of canonical markers of actomyosin tension - phosphorylated myosin light chain (active myosin) and the α-catenin epitope α-18. By comparing the transcriptome of wild-type and snai1b mutant hearts at the early stages of CM extrusion, we found the dysregulation of intermediate filament genes in mutants including the upregulation of desmin b. We tested the role of desmin b in myocardial wall integrity and found that CM-specific desmin b overexpression led to CM extrusion, recapitulating the snai1b mutant phenotype. Altogether, these results indicate that Snai1 is a critical regulator of intermediate filament gene expression in CMs and that it maintains the integrity of the myocardial epithelium during embryogenesis, at least in part by repressing desmin b expression.
In the second part of this study, I focused on the behavior of valve cells during cardiac development. Using the zebrafish atrioventricular valve, I focus on the valve interstitial cells which confer biomechanical strength to the cardiac valve leaflets. We find that initially AV endocardial cells migrate collectively into the cardiac jelly to form a bilayered structure; subsequently, the cells that led this migration invade the extracellular matrix (ECM) between the two EC monolayers, undergo an endothelial-to-mesenchymal transition as marked by loss of intercellular adhesion, and differentiate into VICs. These cells proliferate and are joined by a few neural crest-derived cells. VIC expansion and a switch from a pro-migratory to an elastic ECM drive valve leaflet elongation. Functional analysis of Nfatc1 reveals its requirement during VIC development. Zebrafish nfatc1 mutants form significantly fewer VICs due to reduced proliferation and impaired recruitment of endocardial and neural crest cells during the early stages of VIC development. Analysis of downstream effectors reveals that Nfatc1 promotes the expression of twist1b, a well-known regulator of epithelial-to-mesenchymal transition. This study shows for the first time that Nfatc1 regulates zebrafish VICs formation regulating valve EMT in part by regulating twist1b expression. Moreover, it proposes the zebrafish valve as an excellent model to study the cellular and molecular process that regulate VIC development and dysfunction.
In conclusion, my work: 1) identified an unsuspected role of Snai1 in maintaining the integrity of the myocardial epithelium, opening new avenues in its role in regulating cellular contractility; 2) uncovered the function of Nfatc1 in the establishment of the VIC, establishing a new model to study valve development and function.
Despite all advancements in cancer research and clinical practice, cancer remains a life- threatening disease with an increasing incidence. According to a 2018 WHO forecast, cancer incidence will double to approximately 37 million new cancer cases by 2040. Today, clinical management of cancer is based on a "one-fits-all" strategy. Most cancers are still treated by surgical therapy followed by adjuvant or neoadjuvant chemotherapy based on rather strict guidelines (S3 guidelines in Europe) which are based on studies of large cohorts of patients with the same tumor entity. While this approach has led to substantial increases in progression-free survival and overall patient survival, most patients do not benefit from the administered treatment regimen. One reason for this is intra-tumor heterogeneity, which results from clonal evolution between cancer cells and their environment. This means that cancer patients may respond differently to a particular drug due to the different mutation patterns of their tumor cells. Therefore, patients should be screened in advance for reliable cancer biomarkers that definitively predict whether they will respond to a particular therapy. This would increase the probability of a successful treatment.
Colorectal cancer (CRC) is the third most diagnosed cancer and the second leading cause of cancer deaths worldwide. The main cause of death in CRC is a metastatic disease, which is presented in 20 % of patients and eventually develops in more than 30 % of early-stage patients. Despite the significant increase (to more than 30 months) in median survival with the development of cytotoxic agents and the introduction of targeted therapy, the progression-free survival in the first-line setting has remained largely unchanged over the past decade.
The heterogeneity in CRC is characterized by alterations in multiple signaling pathways that affect cellular functions such as cell proliferation or apoptosis. Commonly affected signaling pathways include the mitogen-activated protein kinase (MAPK)- and the transforming growth factor-β/bone morphogenetic protein (TGF-β/BMP)-pathway. Alterations in the TGF-β/BMP pathway, due to mutations in the SMAD4 gene (mothers against decapentaplegic homolog 4), are associated with different drug response and promote resistance to chemotherapy. In addition, they are associated with a higher recurrence rate.
SMAD4 is one of the most common cancer driver genes, and mutations occur in up to 15 % of CRC cases. Therefore, there is an urgent need for therapeutic agents that can specifically target SMAD4-mutated tumors.
The aim of the present study was the identification of the clinical relevance of the SMAD4 gene and the investigation of its suitability as a potential biomarker in CRC.
For this purpose, I investigated sibling patient-derived organoids (PDOs) derived from different regions of a chemo-naïve CRC tumor. PDOs are 3D cell cultures that reliably recapitulate the architecture of the tissue of origin, as well as preserve the genomic background and intra-tumor heterogeneity. The sibling PDOs (R1R361H and R4wt) shared the most common CRC mutations, such as KRASG12D (kirsten rat sarcoma), PIK3CAH1047R (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha), and TP53C242F (tumor protein 53), but differed in a SMAD4R361H mutation and showed a different drug response. The single nucleotide variant R361H of the SMAD4 gene is among the most common pathogenic alterations in various cancers, including CRC.
The sibling PDOs showed significant differences in response to the MEK-inhibitors cobimetinib, trametinib, and selumetinib. MEK-inhibitors are antineoplastic agents that inhibit the function of MEK1 and MEK2, preventing phosphorylation of transcription factors, which leads to inhibition of tumor cell proliferation. MEK-inhibitors are approved for the treatment of malignant melanoma. Currently, they are in phase-III clinical trials for the treatment of patients with metastatic CRC.
To investigate whether SMAD4R361H is responsible for sensitivity to MEK-inhibitors, Iestablished three syngeneic PDOs harboring a SMAD4R361H mutation using the CRISPR/Cas9 genome editing system. All CRISPR-PDOs were significantly more sensitive to the MEK-inhibitors, compared to R4wt. I have shown that the SMAD4R361H mutation is responsible for sensitivity to MEK inhibition in CRC models and may be a predictive biomarker.
To test this hypothesis, I examined 62 CRC PDO models and treated them with the MEK-inhibitors cobimetinib, trametinib, and selumetinib. All models that had a pathogenic mutation or deletion in the SMAD4 gene (15 %) were sensitive to cobimetinib, 10 % of models were sensitive to trametinib, and 8 % were sensitive to selumetinib.
I performed transcriptome (RNA sequencing) and proteome analyses using the DigiWest® method to investigate the mechanism underlying MEK-inhibitor sensitivity.
DigiWest® is a Luminex® bead-based analysis that allows the simultaneous analysis of over 100 (phospho-)proteins. The transcriptome and proteome data support the observation that MEK inhibition primarily affects SMAD4R361H PDOs. Furthermore, I have shown that activation of the BMP signaling pathway in organoids with wild-type SMAD4 appears to be responsible for resistance to MEK-inhibitors. Thus, a genetic alteration in the BMP signaling pathway, beyond SMAD4, could lead to sensitivity to MEK-inhibitors.
I identified four genes involved in the TGF-β/BMP signaling pathway that are frequently mutated in CRC and grouped them into the so-called SFAB-signature (SMAD4, FBXW7 (F-box/WD repeat-containing protein 7), ARID1A (AT-rich interactive domain-containing protein 1A), or BMPR2 (Bone morphogenetic protein receptor type II). Clinical data show that approximately 36 % of CRC patients have at least one pathogenic mutation in these genes.
I tested all 62 CRC PDO models and found a significant positive prediction for sensitivity to cobimetinib (95 %) and selumetinib (70 %) for the SFAB-signature. Trametinib and the newly approved MEK-inhibitor binimetinib showed a similar trend. Therefore, the SFAB-signature has high predictive power for response to MEK-inhibitors and could be used as a predictive biomarker panel.
The current clinically used biomarkers for CRC are based on the mutation status of driver genes KRAS and BRAF, which are present in up to 50 % and 10 % of CRC, respectively. Investigation of molecular alterations in CRC revealed that mutations in the KRAS gene, which is downstream of EGFR (epidermal growth factor receptor) in the MAPK-pathway, interfere with an anti-EGFR-antibody therapy (e.g., cetuximab). Therefore, cetuximab is only relevant for RAS wild-type tumors. However, approximately 40 % of patients with RAS wild-type status do not respond to this treatment.
About 53 % of CRC PDO models carry a pathogenic RAS mutation, about 10 % harbor a pathogenic BRAF mutation. Both, the RAS and RAF status alone as well as the combination of RAS and RAF status with SFAB-signature did not provide a better prediction of sensitivity to MEK inhibition.
Eine große Gruppe von Aptameren sind die Guanosintriphosphat (GTP) Aptamere. Diese zeigt sehr eindrücklich, wie RNA unterschiedliche Strategien nutzt, um denselben Liganden zu erkennen. Die komplette Struktur des GTP Klasse II Aptamers wird in der ersten Publikation gezeigt. Interessanterweise zeichnet die Struktur ein stabil protoniertes Adenine unterhalb der GTP-Bindestelle aus. Dieses wurde durch eine Kombination aus weiterführenden NMR- und ITC-Experimente untersucht und charakterisiert. Es zeigte sich, dass die protonierte Base einen pKs-Wert hat, der weit von der Neutralität verschoben ist. Die Protonierung ist auch noch bei sehr basischen Puffern stabil.
Eine Art der funktionellen Protonierung wird von den zyklischen di-Nukleotiden (CDN) bindenden Riboswitches genutzt, um zwei CDN mit ähnlicher Affinität zu binden. c-di-GMP Riboswitches wurden als regulatorische Einheit beschrieben und deren Kristallstruktur aufgeklärt. Mutationsexperimente führten dazu, dass bei einer G-zu-A Mutation an der Gα-Bindestelle die Selektivität des Riboswitches verändert wurde. Die Mutante bindet sowohl c-di-GMP als auch cGAMP mit ähnlichen Bindungsaffinitäten. Riboswitche, die cGAMP binden wurden auch in der bakteriellen Genomen gefunden. Hierbei ist die Promiskuität unterschiedlich stark ausgeprägt. Die Untersuchung des Bindungsmodus und der damit verbundenen Promiskuität ist in der zweiten Publikation beschrieben. Hier wurde gezeigt, dass die Riboswitche beide Liganden nur binden können, wenn zur Bindung von c-di-GMP das Ligand bindende A protoniert vorliegt. Auch diese Protonierung konnte mit weiterführenden NMR- und ITC-Experimenten charakterisiert werden. Die Untersuchungen einer solch großen RNA sind mit NMR Spektroskopie herausfordernd. Hierbei wurde ausgenutzt, dass die Kristallstruktur bereits bekannt war, welche allerdings die Protonierung nicht zeigte. Auch diese Protonierung zeigt einen pKs-Wert, der weit von der Neutralität verschoben ist und außerdem bei unterschiedlichen pH stabil ist.
In den beiden untersuchten Beispielen wurden zwei verschiedene Arten von Protonierung gezeigt: eine strukturelle und eine funktionelle. Das GTP Klasse II Aptamer benutzt die Protonierung als strukturelle Basis für die Basis der Ligandenbindungsstelle. Hierbei werden durch die Protonierung des Adenines mehr nutzbare Wasserstoffbrücken ausgebildet und damit die Tertiärstruktur stabilisiert. Im Unterschied dazu nutzen die promiskuitiven CDN Ribsowicthes die Protonierung, um verschiedene Liganden binden zu können und es kommt damit zu einer Verschiebung der Funktionalität. Der regulatorische Nutzen dafür ist allerdings noch unbekannt.
Auch bei den SAM Riboswitches wurde ein promiskuitiver Vertreter beschrieben. SAM Riboswitches gehören zu den am längsten bekannten Klassen der Riboswitches. Bis heute sind hier die meisten unterschiedlichen Klassen bekannt. SAM wird häufig als Donor für funktionelle Gruppen benutzt, besonders häufig als Methlygruppendonor für die Methylierung einer Reihe unterschiedlicher Substrate (z.B. DNA, Proteine, Metabolite etc.). Bei dieser Reaktion entsteht SAH als Nebenprodukt. Zusätzlich ist SAH zelltoxisch, da es affin an Methyltransferasen bindet und damit diese essenzielle Reaktion inhibiert. Eine enge Kontrolle der SAH-Konzentration ist daher kritisch. SAM bindende Riboswitches haben zu SAM eine bis zu 1000-fach höhere Bindungsaffinität im Vergleich zu SAH. Die Beschreibung eines translationalen OFF-Riboswitches, der SAM und SAH mit ähnlicher Affinität bindet, ist daher überraschend. Zumal seine Genassoziation fast ausschließlich zu SAM Synthetasen ist, deren Regulation durch SAH wenig sinnvoll erscheint. Um ein besseres Verständnis für die Funktion des SAM/SAH Riboswitches zu erhalten, wurde seine 3D-Struktur mittels NMR-Spektroskopie aufgeklärt, wie in der vierten Publikation beschrieben. Dafür mussten zunächst alle Resonanzen der Sequenz und dem Liganden zugeordnet werden, wie in der dritten Publikation beschrieben. Dabei wurde als Ligand SAH gewählt, da dieser chemisch stabiler und damit für die teils tagelangen NMR-Messungen besser geeignet ist. Zusätzlich wurden Mutanten bzw. verwandte Liganden mittels ITC Experimente auf ihre Bindungseigenschaften untersucht, um die Bedeutung der Linkerlänge, einzelner Basenpaare und funktionelle Gruppen des Liganden zu untersuchen. Bei anderen bekannten SAM Riboswitches umschließt die RNA den Liganden fast komplett. Dabei wird zum einem das Sulfoniumion spezifisch durch die Carboxylgruppen verschiedener Uracil-Nukleotide erkennt und koordiniert. Außerdem bildet sich eine Bindetasche aus, die genug Platz für die stabile Bindung der Methylgruppe hat. Beim SAH Riboswitch wird die Selektivität für SAH dadurch erreicht, dass die Bindetasche sterisch keinen Platz für die Methylgruppe von SAM bereitstellt.
Zusammenfassend wurden in dieser Arbeit drei verschiedene Ligand bindende RNA-Strukturen untersucht, die alle sehr unterschiedliche Strategien zur Bindung der Liganden nutzen. Obwohl Portionierungen bei Aptameren und Riboswitches selten beschrieben wurden, haben sie eine maßgebliche Funktion in den beiden zuerst untersuchten Strukturen. Obwohl bisher im Hinblick auf alle bekannten RNA Strukturen eher selten beschrieben, gibt es doch neben den genannten zwei, einige Beispiele für strukturelle oder funktionelle Protonierungen. Auch in Hinblick auf zukünftige bzw. Verbesserung bestehender RNA-Strukturvorhersage-Programme ähnlich wie sie für Proteine schon lange nutzt werden, müssen protonierte Nukleobasen ernsthaft in Betracht gezogen werden. Außerdem konnte gezeigt werden, dass zwei der untersuchten Riboswitches zwei Liganden mit ähnlicher Affinität binden. Die genutzte Strategie ist hierbei unterschiedlich. Während bei den promiskuitiven CDN Riboswitches der regulatorische Nutzen noch unbekannt ist, konnte für den SAM/SAH Ribsowitch gezeigt werden, dass SAH nur zufällig aufgrund der wahrscheinlich sehr niedrigen intrazellulären Konzentration gebunden wird und dieser daher wahrscheinlich später in der evolutionären Entwicklung entstanden ist. Riboswitches halten es weiterhin spannend.
The intensive use of the North Sea area through offshore activities, sand mining, and the spreading of dredged material is leading to increasing pollution of the ecosystem by chemicals such as hydrophobic organic contaminants (HOCs). Due to their toxicological properties and their ability to accumulate in the environment, HOCs are of particular concern. The contaminants partition between aqueous (pore water, overlying water) and solid phases (sediment, suspended particulate matter, and biota) within these systems. The accumulated contaminants in the sediment are of major concern for benthic organisms, who are in close contact with sediment and interstitial water. It is thus particularly important to better understand how contaminants interact with biota, as these animals may contribute to trophic transfer through the food web. Furthermore, sediments are a crucial factor for the water quality of aquatic systems. They not only represent a sink for contaminants but also determine environmental fate, bioavailability, and toxicity. The Marine Strategy Framework Directive (MSFD) was introduced to protect our marine environment across Europe and includes the assessment of pollutant concentrations in the total sediment, which, however, rarely reflects the actual exposure situation. The consideration of the pollutant concentrations in the pore water is not implemented, although this is needed for the evaluation of bioavailability and risk assessment. For this reason, special attention is given to further development, implementation, and validation of pollutant monitoring methods that can determine the bioavailable fraction in sediment pore water. For risk assessment purposes, it is furthermore important to use biological indicators in addition to classical analytics to determine the effect of pollutants on organisms. The main objective of this thesis was to gain insight into the pollution load and the potential risk of hydrophobic organic chemicals (HOCs) in the sediment of the North Sea and to evaluate these results with regard to possible risks for benthic organisms and the ecosystem. The following five aims are covered within these studies to gain a holistic assessment of sediment contamination:
1. Assessment of the pore water concentrations of PAHs and PCBs
2. Determination of the bioturbation potential by macrofauna analysis
3. Application of the SPME method on biological tissue
4. Assessment of recreated environmental mixtures in passive dosing bioassays
5. Development of SPME method for DDT in sediments
The thesis is comprised of three main studies supported by three additional studies ...
Coupling between epidermis and amphid morphogenesis during embryonic development of C. elegans
(2021)
Sensory organs are fundamental for survival of animal populations, since the detection of environmental stimuli is crucial for localization of nourishment, predators or mating partners. In nematodes, the amphid (AM) sensilla are the largest sensory organs for detection of chemical compounds.
This study investigates how the AM sensilla acquire their special elongated shape during lima-bean to 1.5-fold embryonic stages of C. elegans head development. The dissertation also examines events facilitating the morphogenesis of other head sensilla (IL/OL/CEP) and addresses aspects of general embryonic head morphogenesis. Using high resolution live-cell imaging techniques with different combinations of markers highlighting specific tissues, this study shows that epidermal head enclosure, migration of AM socket cells (pores) and translocation of AM dendrite tips are coupled processes, facilitating the elongation of AM dendrites. Importantly, during AM dendrite elongation the AM neural cell bodies are staying stationary. Manipulation through conducting UV-Laser ablation (epidermis close to pore/pore) and RPN-6.1 dsRNA interference resulted in compromised AM pore migration and impaired dendrite elongation. This leads to the conclusion that AM pores need to be physically attached (through C. elegans apical junctions, CeAJ) to the migrating epidermal sheet and to AM dendrite tips for successful AM morphogenesis. This study infers that RPN-6.1 plays an important role for correct AM pore morphogenesis and AM pore to AM dendrite tip attachment. Our results lead to the conclusion that head enclosure drives AM pore migration and AM dendrite elongation with AM neural cell bodies staying stationary. Thereby, CeAJ are interconnecting AM dendrite tips to AM pores and CeAJ link the sensillar ending to the migrating epidermis. Thus, migration of attached target tissue (pore), with neural cell bodies staying stationary (constituting an abutment), creates a pulling force facilitating AM dendrite elongation. This passive neurite elongation procedure is coined dendrite towing in this study.
Additionally, this study discovers that translocation of IL, OL and CEP head sensilla pores is influenced by apical constriction. This conclusion was made based on the findings that IL/OL/CEP pores migrate towards the prospective mouth anterior to the epidermal leading edge, separated from AM pores and irrespective of highly impaired AM sensilla morphogenesis after strong RPN-6.1 depletion. Also, concurrent with translocation of IL/OL/CEP pores, bottle-shaped cells occur and non-muscle-myosin and apical polarity factors are getting enriched at the anterior most part of the head, indicating de-novo manifestation of apical constriction. It is furthermore assumed that apical constriction in arcade cells might contribute to early pharynx development. All in all, this study reveals two force-generating events: Head enclosure-driven AM sensilla morphogenesis via dendrite towing and, otherwise, apical constriction-facilitated translocation of IL/OL/CEP sensilla pores. These events can get separated by graded depletion of the proteasome activator RPN-6.1.
Autism spectrum disorder (ASD) is a common neurodevelopmental disorder with a multifarious clinical presentation. Even though many genetic risk factors have been identified and studied in mouse models, the neurophysiological mechanisms underlying the autistic phenotype are still unclear. Based on the high rates of comorbidity with epilepsy, it was hypothesized that the balance between excitation and inhibition in neural circuits may be disrupted in autistic individuals.
In this dissertation, synaptic and network activity was measured in three different genetically modified mouse models that exhibit the characteristic behavioral abnormalities of the disorder: the Neurobeachin (Nbea) haploinsufficient mouse, the Neuroligin-3 (Nlgn3) knockout (KO) mouse, and the Neuroligin-4 (Nlgn4) KO mouse. Each of the affected proteins is involved in the formation and/or function of synapses in the central nervous system. Therefore, it was posited that the reduction or deletion of these proteins might alter the balance of excitatory to inhibitory synaptic transmission in individual neurons and in neural circuits. Extracellular recordings in the hippocampal dentate gyrus of anesthetized mice revealed that the excitation-inhibition (E-I) balance was reduced in Nbea haploinsufficient and Nlgn4 KO mice, but unchanged in Nlgn3 KO mice despite a reduction in excitatory synaptic transmission to dentate granule cells. Unexpectedly, the intrinsic excitability of dentate granule cells was altered in all three mouse models. These results imply that a homeostatic increase in the intrinsic excitability is able to compensate for the decreased excitatory transmission in Nlgn3 KO mice, whereas the decreased intrinsic excitability in the Nbea haploinsufficient and Nlgn4 KO mice leads to a reduction in the E-I balance. Taken together, these findings suggest that the influence of genetic factors on the E-I balance might be a potential common mechanism underlying the development of ASD.
Weltweit werden etwa 17% aller Infektionskrankheiten von Vektoren auf den Menschen übertragen. Dabei dienen meist blutsaugende Arthropoden wie Stechmücken, Zecken oder Sandfliegen als Überträger von Bakterien, Viren oder einzelligen Parasiten. Zur letzteren Gruppe gehört auch der protozoische Erreger der Chagas-Krankheit Trypanosoma cruzi. Er wird von hämatophagen Triatominae, einer Unterfamilie der Raubwanzen (Hemiptera: Reduviidae) während der Blutmahlzeit an einem infizierten Säugerwirt aufgenommen, durchläuft komplexe Entwicklungsschritte im intestinalen Trakt der triatominen Insekten und wird anschließend über den Fäzes und Urin der Wanzen abgegeben. Die Infektion des nächsten Wirts erfolgt dann durch das versehentliche Einreiben der Erreger in die Stichwunde oder auf Schleimhäute. Auch eine Infektion über die orale Aufnahme von kontaminierter Nahrung, Mutter-Kind-Infektionen und die Übertragung durch Blutkonserven und Organtransplantate sind möglich. Die Chagas‑Krankheit, oder auch Amerikanische Trypanosomiasis, ist insbesondere in Mittel- und Südamerika verbreitet und betrifft nach Schätzungen der WHO 6 bis 7 Millionen Menschen. Infolge von globaler Immigration und erhöhtem Reiseverkehr treten jedoch in den letzten Jahrzehnten auch vermehrt Fälle in Europa, den USA, Kanada und den westlichen Pazifikstaaten auf. Da dort bislang geeignete Vektoren fehlen, kommt es außerhalb des lateinamerikanischen Kontinents nicht zu vektorübertragenen Infektionen. Dies könnte sich jedoch im Zuge des Klimawandels und einer voranschreitenden Globalisierung ändern, sollte der Ausbreitung der Chagas-Krankheit eine Ausbreitung ihrer triatominen Vektoren folgen.
Inwieweit Triatominae unter heutigen Bedingungen klimatisch geeignete Habitate außerhalb des amerikanischen Kontinents finden, wurde innerhalb des ersten Projekts der vorliegenden Dissertation untersucht. Dazu wurde mit Hilfe der ökologischen Nischenmodellierung und Vorkommensdaten verschiedener vektorkompetenter Raubwanzenarten sowie klimatischer Umweltvariablen die klimatische Eignung verschiedenster Lebensräume modelliert und global projiziert. Es zeigte sich, dass insbesondere tropische und subtropische Gebiete Afrikas sowie Ost- und Südostasiens zwischen 21° nördlicher Breite und 24° südlicher Breite für viele triatomine Vektorarten geeignete Bedingungen aufweisen. Auffällig ist dabei insbesondere die Art Triatoma rubrofasciata, welche nachweislich bereits in Südchina, Vietnam und weiteren Ländern Afrikas und Asiens gefunden wurde. Die Modellierung
offenbarte, dass weitere ausgedehnte Teile der Küstenregionen Afrikas und Südostasiens als für T. rubrofasciata klimatisch geeignet angesehen werden müssen. Eine weitere Ausbreitung dieser Art ist demnach äußerst wahrscheinlich und stellt bislang das größte Risiko autochthon übertragener Chagas-Infektionen außerhalb des amerikanischen Kontinents dar. Es konnten außerdem zwei triatomine Arten identifiziert werden, namentlich T. infestans und T. sordida, welche in gemäßigten Klimazonen geeignete Habitate finden. Zu diesen gehören beispielsweise Neuseeland und Teile Australiens, aber auch südeuropäische Länder wie Spanien, Italien, Griechenland und Portugal. Da mit einer Ausweitung der klimatisch geeigneten Gebiete infolge des sich verändernden Klimas zu rechnen ist, wäre ein Monitoring der Vektoren, wie es bereits in Südchina etabliert ist, aber insbesondere die Einführung der Meldepflicht für Amerikanische Trypanosomiasis in diesen Regionen sinnvoll. Die Ergebnisse der Studie zeigen deutlich, dass die bisher vernachlässigte Tropenkrankheit Chagas nicht allein ein Problem des lateinamerikanischen Kontinents ist, sondern deren Erforschung vielmehr weltweit Beachtung finden sollte.
So konzentrierten sich die folgenden Forschungsprojekte der Promotion verstärkt auf die Mechanismen, welche die Entwicklung und Transmission des Parasiten und die Interaktion mit seinen Vektoren betreffen. Von besonderem Interesse waren dabei die ökologischen Prozesse, welche bei der Kolonisation des Darmtrakts der Vektoren durch T. cruzi ablaufen und essentiell für die Proliferation und damit die Übertragung des Parasiten sind. Eine entscheidende Rolle spielen dabei die mit dem Vektor assoziierten Mikroorganismen und ihre funktionellen Fähigkeiten – zusammengefasst als Mikrobiom bezeichnet. Dieses erfüllt wichtige physiologische Funktionen des Insekts und kann beispielsweise das Immunsystem und die Detoxifikation beeinflussen. Um die Veränderungen der organismischen Zusammensetzung und der funktionellen Kapazitäten, welche die Infektion mit dem Pathogen im Darmtrakt der Vektoren auslösen, zu untersuchen, wurde ein metagenomischer Shotgun Sequenzierungsansatz gewählt. Die daraus resultierenden Datensätze wurden anschließend bioinformatisch ausgewertet und auf ihre mikrobielle Zusammensetzung und metabolischen Fähigkeiten hin untersucht. Es zeigte sich zunächst, dass das Bakterium Rhodococcus rhodnii, welches lange als alleiniger echter Symbiont des untersuchten Vektors Rhodnius prolixus galt, in seiner Funktionalität nicht einzigartig im Mikrobiom des Insekts ist. ...
In Zeiten der globalen Klimaerwärmung und des Klimawandels werden Strategien zur Vermeidung, Reduzierung oder Wiederverwertung von CO2-Emissionen sowie die Abkehr von fossilen Energieträgern immer wichtiger. Aus diesem Grund finden Technologien zur Bindung, Speicherung und Wiederverwertung von CO2 immer größere Aufmerksamkeit und diverse chemische als auch biologische Ansätze werden verfolgt. Eine dieser Möglichkeiten umfasst die Reduktion von CO2 mit Hilfe von molekularem Wasserstoff. Im Prozess der direkten Hydrogenierung von CO2 zu Ameisensäure bzw. Formiat wird nicht nur CO2 gebunden, sondern ebenfalls H2 in flüssiger Form gespeichert. Die Ameisensäure weist gegenüber dem hochflüchtigen Wasserstoffgas verschiedene Vorteile auf und zählt zu der Gruppe der flüssigen, organischen Wasserstoffspeicherverbindungen. Daneben ist das Einsatzgebiet von Ameisensäure als Ausgangstoff für Chemikalien oder als mikrobielle Kohlenstoffquelle sehr vielseitig und die Verbindung erfreut sich zunehmenden Interesses.
Die Natur hält biologische Katalysatoren (Enzyme) für die Reduktion von CO2 bereit. Die Gruppe der obligat anaeroben, acetogenen Bakterien verwendet so genannte Formiatdehydrogenasen als CO2-Reduktasen, um CO2 im Wood-Ljungdahl-Weg (WLP) der Bakterien fixieren zu können. Diese Enzyme katalysieren die reversible 2-Elektronen Reduktion von CO2 zu Ameisensäure. Kürzlich konnte aus den beiden Vertretern A. woodii (mesophil) und T. kivui (thermophil) ein neuartiger, cytoplasmatischer Enzymkomplex isoliert werden. Dieser Enzymkomplex koppelt die Reduktion von CO2 direkt an die Oxidation von H2 und wird deshalb als Wasserstoff-abhängige CO2-Reduktase bezeichnet (engl. hydrogen-dependent CO2 reductase, HDCR). Die HDCR katalysiert dabei die reversible Hydrogenierung von CO2 zu Formiat mit annähernd gleicher Kinetik und gleichen Umsatzraten. Die bei der CO2 Reduktion erreichten Umsatzraten übertrafen dabei bisherige chemische als auch biologische Katalysatoren um mehre Größenordnungen.
Im Hinblick auf die besonderen katalytischen Eigenschaften der HDCRs wurde in dieser Arbeit die biotechnologische Anwendbarkeit der Enzyme als Biokatalysatoren zur Speicherung und Sequestrierung von H2 und CO2 in Form von Ameisensäure untersucht. Im Speziellen wurde ein HDCR-basiertes Ganz-Zell-System für das thermophile Bakterium T. kivui entwickelt. Um eine Ganz-Zell basierte Umwandlung von H2 und CO2 zu Formiat zu gewährleisten, wurde zuvor die Weiterverwertung des Formiats zu Acetat im WLP gestoppt. Durch eine Reduktion des zellulären ATP-Gehalts konnte eine weitere Prozessierung des aus der HDCR-Reaktion gebildeten Formiats im Zellstoffwechsel des Bakteriums unterbunden werden. Die Formiatbildung aus H2 und CO2 wurde in Zellsuspensionen von T. kivui untersucht und charakterisiert. Hier zeigten T. kivui Zellen die höchste spezifische Formiatbildungsrate, die bis dato in der Literatur genannt wurde. Ebenfalls wurde in dieser Arbeit die Umwandlung von Synthesegas (H2 + CO2 und CO) und CO zu Formiat geprüft. Bioenergetisch entkoppelte und auf CO-adaptierte T. kivui Zellen konnten in der Tat Synthesegas exklusiv zu Formiat umsetzen. Um die CO-Verwertung zu Acetat und Formiat im Stoffwechsel der Rnf- (A. woodii) und Ech-Acetogenen (T. kivui) verstehen zu können, wurden Mutanten von Δhdcr, ΔcooS, ΔhydBA, Δrnf and Δech2 von A. woodii und T. kivui zur Hilfe genommen. In beiden Organismen war die CO-basierte Formiatbildung vom Vorhandensein eines funktionalen HDCR-Enzymkomplexes abhängig.
Für eine mögliche biotechnologische Anwendung wurde die Maßstabsvergrößerung des Ganz-Zell-Systems angestrebt und hin zum Bioreaktormaßstab mit kontrollierten Prozessbedingungen skaliert. Diese Arbeit demonstriert die effiziente Umwandlung von H2 und CO2 zu Formiat und vice versa unter Verwendung eines Rührkesselreaktors. Der Prozess zeigte eine Effizienz von 100% für die Umwandlung von CO2 zu Formiat und spezifische Raten von 48.3 mmol g-1 h-1 wurden von A. woodii Zellen erreicht. Die spezifische H2-Produktionsrate (qH2) aus der Ameisensäureoxidation betrug 27.6 mmol g-1 h-1 und mehr als 2.12 M Ameisensäure konnte über einen Zeitraum von 195 h oxidiert werden. Wichtige Parameter der Enzymkatalyse wie Wechselzahl (engl. turnover frequency, TOF) und katalytische Produktivität (engl. turnover number, TON) wurden ebenfalls im Versuch bestimmt. Basierend auf dem generierten Prozessverständnis und der effizienten Reversibilität der katalysierten Reaktionen wurde abschließend ein Ganz-Zell-basierter Bioreaktoraufbau gewählt, der die vielfache Speicherung und Freisetzung von H2 in einem einzigen Rührkesselreaktor und unter Verwendung des gleichen Katalysators ermöglicht. Über eine Prozesszeit von 2 Wochen und 15 CO2 Reduktions-/Formiat Oxidations-Zyklen konnte so im Mittel 330 mM Formiat produziert und oxidiert werden.
Zusammenfassend thematisiert diese Arbeit die biotechnologische Anwendbarkeit eines Ganz-Zell-Systems zur Speicherung und Sequestrierung von H2 und CO2 in Form von Formiat und vice versa. Die katalytische Aktivität der betrachteten Organismen fußt dabei auf der Aktivität eines neuartigen Enzymkomplexes, der erstmals in der Gruppe der acetogenen Bakterien entdeckt wurde. Der als Wasserstoff-abhängige CO2-Reduktase bezeichnete Enzymkomplex könnte die zukünftige Konzipierung Enzym-inspirierter und effizienter chemischer Katalysatoren vorantreiben. Auch der Einsatz des Enzyms/der Zellen in so genannten Hydrogelen oder die Etablierung elektrochemischer Prozesse sind vorstellbar. Diese Arbeit stellt somit eine Basis für mögliche zukünftige Anwendungen des etablierten Ganz-Zell-Systems von A. woodii und T. kivui im Bereich der Wasserstoffökonomie dar.
The increasing demand of the high value ω-3 fatty acids due to its beneficial role for human health, explains the huge need for alternative production ways of ω-3 fatty acids. The oleaginous alga Phaeodactylum tricornutum is a prominent candidate and has been investigated as biofactory for ω-3 fatty acids, e.g. the synthesis of eicosapentaenoic acid (EPA). In general, the growth and the lipid content of diatoms can be enhanced by genetic engineering or are influenced by environmental factors, e.g. nutrients, light or temperature.
In this study, the potential of P. tricornutum as biofactory was improved by heterologously expressing the hexose uptake protein 1 (HUP1) from the Chlorophyte Chlorella kessleri.
An in situ localization study revealed that only the full length HUP1 protein fused to eGFP was correctly targeted to the plasma membrane, whereas the N-terminal sequence of the protein is only sufficient to enter the ER. Protein and gene expression data displayed that the gene-promoter combination was relevant for the expression level of HUP1, while only cells expressing the protein under the light-inducible fcpA promoter showed a significant expression. In these mutants an efficient glucose uptake was detectable under mixotrophic growth condition, low light intensities and low glucose concentrations leading to an increased cell dry weight.
In a second approach, the growth and lipid content of wildtype cells were analyzed in a small 1l photobioreactor. Here, a commercial F/2 medium and a common culture medium, ASP and modified versions were compared. There was neither a significant impact on the growth and lipid content in P. tricornutum cells due to the supplemention of trace elements nor due to elevated salt concentrations in the media. In a modified version of ASP medium, with adapted nitrate and phosphate concentration a constantly high biomass productivity was achieved, yielding the highest value of 82 mg l-1 d-1 during the first three days. This was achieved even though light intensity was reduced by 40%. The differences in biomass productivity as well as the lipid content and the lipid composition underlined the importance of the choice of culture medium and the harvest time for enhanced growth and EPA yields in P. tricornutum.
With 5-10 newly diagnosed patients per 100,000 people every year, glioblastoma is the most common malignant primary brain tumor. Despite extensive research activity in the last decades, clinical effectiveness of the currently available therapy standard of surgery, radiochemotherapy and tumor-treating fields is still limited and mean survival rates in unselected collectives are only about one year. Accordingly, there is an urgent need to explore new therapeutic options. The current standard of care includes surgery followed by radiation therapy in combination with the alkylating chemotherapeutic agent Temozolomide. Even with successful initial therapy, tumor recurrence is still inevitable. Currently, there are no defined recommendations for clinical management of the disease in the event of tumor recurrence. Only 20-30% of patients qualify for a second surgical resection, while other options include retreatment with Temozolomide, CCNU (Lomustine) or Regorafenib and enrollment in a clinical trial.
The development of immunotherapies for glioblastoma, in particular, has been the focus of intense preclinical and clinical efforts. However, low numbers of mutations and a highly immunosuppressive tumor microenvironment result in glioblastoma being considered an immunologically “cold” tumor. Strategies successfully established in mutagen-induced tumors with antibodies directed against the PD-1, PD-L1 or CTLA-A4 immune checkpoints have therefore failed in glioblastoma.
Cellular immunotherapies based on chimeric antigen receptor (CAR)-technology have emerged as an alternative powerful option to tackle immunologically “cold” tumors. Several CAR-T cell products targeting glioma antigens have been developed and some evidence of clinical activity has been demonstrated. Natural killer (NK) cells as carriers of CAR constructs have several advantages over T cells, including a much lower risk of neurotoxicity and better interaction with immune cells in the microenvironment. Based on the human NK cell line NK-92, a clinical-grade product, suitable as an off-the-shelf therapeutic, has been developed. The NK-92/5.28.z clone (CAR-NK) expresses a CAR based on the HER2-specific antibody FRP5 in addition to signal-enhancing CD28 and CD3ζ domains. Similar to several other tumor entities, overexpression of the growth factor receptor HER2 is often found in glioblastoma patients. Because of its substantial role in the regulation of cell proliferation, survival, differentiation, angiogenesis and invasion, this receptor is classified as an oncogene. HER2 overexpression plays a major role in the malignant transformation of cells and its oncogenic potential has been studied in detail in breast cancer. However, HER2 expression was also found in up to 80% of glioblastomas, which correlates with an impaired probability of survival. Under physiological conditions, HER2 is not expressed in the adult central nervous system, making it a promising target antigen for glioblastoma immunotherapy.
In previous projects, it has already been shown that these CAR-NK cells exhibit a high and specific lytic activity towards HER2+ glioblastoma cells. While repetitive intratumoral injections of CAR-NK cells already significantly extended symptom-free survival in murine orthotopic xenograft models, CAR-NK cell therapy in immunocompetent mice promotes an endogenous anti-tumor immune response which improves tumor control and provides persisting anti-tumor immunity after therapy of early-stage tumors. However, in more advanced tumor models, efficacy is limited and induction of the checkpoint-molecule PD-L1 in response to CAR-NK-cell therapy was identified as a key mechanism of therapy resistance.
Immunotherapy employing the intravenous administration of checkpoint inhibitors has already revolutionized the treatment of various malignant diseases such as melanoma or lung cancer. In particular, the approach of cancer immunotherapy has focused on the systemic administration of antibodies directed against immune checkpoints such as PD-1, PD-L1 and CTLA-4. In glioblastoma, both tumor cells and microglia, the brain-resident macrophages, express PD-L1, which hinders the activation of CD8+ and CD4+ T cells. Therefore, immunotherapy directed against the PD-1/PD-L1 axis represents a promising approach for the treatment of glioblastoma. One problem, however, is the severe toxicity caused by the systemic effects of checkpoint inhibitors, since the immune response is stimulated not only in tumor tissue but also in healthy organs. Serious side effects such as colitis, hepatitis, pancreatitis or hypophysitis, including numerous deaths, have been reported.
This study aimed to improve the efficacy of CAR-NK cell therapy by combining it with adeno-associated virus (AAV)-mediated transfer of anti-PD-1 antibodies as a strategy to enable local combination therapy to control intracranial tumors.
AAVs carrying a payload coding for an anti-PD-1 immunoadhesin (aPD-1) retargeted to HER2-expressing cells by fusion of so-called Designed Ankyrin Repeat Proteins (DARPins) with a viral capsid protein were employed for this to focus checkpoint inhibitor therapy to the tumor area, resulting in high intratumoral and low systemic drug concentrations. ...
Sleep is one of the fundamental requirements of all animals from nematodes to humans. It appears in different formats with shared features such as reduced muscle activities and reduced responsiveness to the environment. Despite the long history of sleep research, why a brain must be taken offline for a large portion of each day remains unknown. Moreover, sleep research focused on mammals and birds reveals two stages, rapid-eye-movement (REM) and slow-wave (SW) sleep, alternating during sleep. Whether these two stages of sleep exist in other vertebrates, particularly reptiles, is debated, as is the evolution of sleep in general.
Recordings from the brain of a lizard, the Australian bearded dragon Pogona vitticeps, indicate the presence of two electrophysiological states and provides a better picture of their sleep. Local field potential (LFP) signals, head velocity, eye movements, and heart rate during sleep match the pattern of REM and SW sleep in mammals. The SW and REM sleep patterns that we observed in lizards oscillated continuously for 6 to 10 hours with a period of 80-100 seconds when the ambient temperature was ~27°C. Lizard SW dynamics closely resemble those observed in rodent hippocampal CA1, yet originated from a brain area, the dorsal ventricular ridge (DVR), that does not correspond anatomically or transcriptomically to the mammalian hippocampus. This finding pushes back the probable evolution of these dynamics to the emergence of amniotes, at least 300 million years ago.
Unlike mammals and birds, REM and SW sleep in lizards occupy an almost equal amount of time during sleep. The clock-like alternation between these two sleep states was found initially by measuring the power modulation of two frequency bands, delta and beta. I recorded the full-band LFP and found an infra-slow oscillation (ISO) in the frequency range between 5 and 20 milli-Hz during sleep. The magnitude of ISO increased during sleep and decreased during both wakefulness and arousal during sleep. The up- and down-states of ISO were synchronized with the sleep state alternating rhythm but with a significant time lag dependent on the locations of the recording electrodes. Multi-site LFP recordings indicated that this ISO is a putative propagation wave sweeping extremely slowly, 30-67 µm/sec, from the posterior-dorsal pole to the anterior-ventral pole of the DVR.
Previous studies in other animals showed that brainstem areas such as the locus coeruleus, laterodorsal tegmentum, and periaqueductal gray are involved in sleep states regulation. It is sadly impossible to carry out in vivo recordings in the lizard brainstem without severely affecting them and their quality of life. I thus carried out ex vivo recordings in both DVR and brainstem. Pharmacological stimulation of the brainstem could reversibly silence one distinct EEG pattern characteristic of SW sleep, the sharp-wave and ripple complex, in DVR. An ISO could be recorded simultaneously in both DVR and brainstem. From data collected in both intact and split ex vivo brains, I concluded that there are independent ISO generators in at least two areas, the brainstem and the telencephalon. Their signals may normally be synchronized by long-range connections. The DVR ISO leads the brainstem ISO by ~29 sec. Optogenetic stimulation of brainstem neurons was able to disrupt the ISO in DVR reversibly.
In conclusion, the lizard brain offers a relatively simple model system to study sleep. Despite a diversity of results in different lizard species, my results revealed a number of new findings. Relevant for sleep research in general: 1) REM and SW sleep exist in a reptile. Since they also exist in birds and mammals, they probably existed in their common amniote ancestor, if not earlier. 2) REM and SW occupy equal amounts of time during sleep (50% duty cycle), a unique feature among all described sleep electrophysiological patterns, suggesting the possible existence of a simple central pattern generator of sleep, possibly ancestral. 3) I discovered the existence, in the local field potential, of an infra slow oscillation with extremely slow propagation, locked to the SW-REM alternating rhythm. The causes and mechanisms of this ISO remain to be understood. To my knowledge, the correlation between sleep states and a slow rhythm has only been reported in human scalp EEG recordings so far.
Thermoanaerobacter kivui ist ein thermophiles acetogenes Bakterium, das chemolithoautotroph auf CO2 unter Verwendung von molekularem H2 als Elektronendonor wächst und Acetat als Produkt über den Wood-Ljungdahl-Weg (WLP) bildet. Im WLP werden 2 Mol CO2 reduziert, um ein Mol Acetyl-CoA zu bilden. Erste Studien wurden durchgeführt, um die Physiologie von T. kivui zu verstehen. T. kivui wächst autotroph auf H2 + CO2 und nach Adaptation auch auf CO oder Syngas. T. kivui wächst ebenfalls auch in Minimalmedium ohne weitere Zugabe von Vitaminen, was es zu einem Biokatalysator mit hohem Potenzial für die Produktion von Chemikalien mit hohem Mehrwert macht. Heterotroph wächst T. kivui auf Glucose, Fructose, Mannose, Pyruvat oder Formiat. Kürzlich wurde beschrieben, dass T. kivui in der Lage ist, auf dem Zuckeralkohol Mannitol in Gegenwart und Abwesenheit von HCO3- (oder externem CO2) zu wachsen. Allerdings war das Wachstum in Abwesenheit von externem CO2 deutlich verlangsamt. Daher wurde in dieser Studie getestet, ob eine Zugabe von externem Formiat das "fehlende" CO2 kompensieren kann. In Kombination mit Formiat wurde das Wachstum auf Mannitol in CO2 und HCO3- freien definierten Medien bis zu einer maximalen OD600 von 2,34 und mit einer Verdopplungszeit von 2,0 ± 0,0 stimuliert, was dem Wachstumsverhalten auf Mannitol in Anwesenheit von CO2/HCO3- entsprach. In Abwesenheit von Formiat (oder CO2) erreichte T. kivui nur eine endgültige optische Dichte von bis zu 0,7 mit einer verlängerten Verdoppelungszeit von 5,2 ± 0,2 Stunden. Dieses Experiment zeigte die höhe metabolische Flexibilität von T. kivui durch die Nutzung von Formiat als Elektronenakzeptor, wenn kein oder nur wenig CO2 vorhanden ist.
Genomanalysen ergaben, dass T. kivui ein Trehalose- und Maltose-Transportsystem-Permeaseprotein (MalF) besitzt. Darüber hinaus verfügt T. kivui über Trehalose- und Maltosehydrolase-Gene, die als Kojibiose-Phosphorylase annotiert sind. Obwohl in der Originalveröffentlichung beschrieben wurde, dass der Organismus nicht auf Maltose oder Trehalose wachsen kann, konnte T. kivui im Laufe dieser Arbeit an das Wachstum auf Maltose und Trehalose adaptiert werden. Nach dem Transfer von einer Glukose-Vorkultur auf ein Medium mit 25 mM Maltose oder 25 mM Trehalose als alleinige C-Quelle wurde kein Wachstum erzielt. Bei Verwendung der gleichen Vorkultur in einem Medium mit höherer Konzentration (50 mM) Maltose oder Trehalose, begannen die Zellen zu wachsen. Bei Verwendung dieser adaptierten kulturen als Vorkultur wuchsen die Zellen in Gegenwart von in 25 mM Maltose oder Trehalose bis zu einer maximalen OD600 von 1,12 bzw. 0,73. Die Adaptation hing mit der Tatsache zusammen, dass der Organismus eine höhere Konzentration benötigt, um sich an diese Kohlenstoffquellen zu gewöhnen. Durch diese Daten wird das heterotrophe Potenzial von T. kivui erhöht.
Um die Bedeutung der wasserstoffabhängigen Kohlendioxidreduktase (HDCR) während des Wachstums auf Formiat oder auf H2 + CO2 im Stoffwechsel von T. kivui zu verstehen, wurden Studien auf molekularer Ebene durchgeführt. Die HDCR nutzt H2 direkt für die Reduktion von CO2 zu Formiat im ersten Schritt des Wood-Ljungdahl-Wegs (WLP). Um die Rolle der HDCR in dieser Reaktion zu untersuchen, wurde das hdcr-Gencluster mit Hilfe des kürzlich entwickelten Mutagenesytems für T. kivui deletiert. In Wachstumstudien konnte anschliessend gezeigt werden, dass die ߡhdcr-Deletionsmutante nicht mehr auf Formiat oder H2 + CO2 als alleiniger Kohlenstoffquelle wachsen konnte. Nach Komplementation der Mutante mit dem hdcr-Gene in cis wuchsen die Kulture wieder auf Formiat oder H2 + CO2. Diese Experimente zeigten, dass die HDCR für das Wachstum auf H2 + CO2 oder Formiat essentiell ist. Interessanterweise konnte in der ߡhdcr-Mutante ebenfalls ein verändertes Wachstum auf Glukose als alleiniger C-Quelle festgestellt werden. Die T. kivui ߡhdcr-Mutante wuchs nur bis zu einer OD600 von 0,2, während der Wildtyp und der hdcr-komplementierte Stamm bis zu einer OD600 von 2,64 bzw. 2,4 wuchsen. Damit wurde bewiesen, dass die HDCR auch für die vollständige Glukoseoxidation in T. kivui erforderlich ist. Durch die Zugabe von Formiat wurde das Wachstum vollständig wiederhergestellt, ähnlich wie beim Wildtyp. Dies belegt wieder die Nutzung Formiat als terminalen Elektronenakzeptor. Auch auf Mannitol oder Pyruvat konnte die Mutanten nur in Gegenwart von Formiat wachsen. Der Substratverbrauch und die Produktbildung der T. kivui ߡhdcr-Mutante wurden in einem Zellsuspensionsexperiment untersucht. Die Zellen verbrauchten Formiat nur in Gegenwart von Glukose und produzierten Acetat mit einem Acetat/Substrat-Verhältnis von etwas mehr als 3,0, während die Acetatproduktion nur 12 mM betrug, wenn Glukose als alleiniges Substrat verwendet wurde. Diese Ergebnisse zeigen eine enge Kopplung der Oxidation von Multikohlenstoffsubstraten an den WLP.
T. kivui ist eines der wenigen Acetogenen, die CO als einzige Kohlenstoff- und Energiequelle nutzen können. ...
Genetic engineering of Saccharomyces cerevisiae for improved cytosolic isobutanol biosynthesis
(2021)
The finite nature of fossil resources and the environmental problems caused by their excessive usage requires alternative approaches. The transformation from a fossil based economy to one based on renewable biomass is called a “bioeconomy”. To substitute fossil resources, various microorganisms have already been modified for the biosynthesis of valuable chemicals from biomass. However, the development of such efficient microorganisms at an industrial scale, remains a major challenge. The most prominent and robust microorganism for industrial production is the yeast Saccharomyces cerevisiae, which is known to produce ethanol that is used as renewable biofuel. However, S. cerevisiae is also naturally able to produce isobutanol in small amounts. Isobutanol is favoured as a biofuel compared to ethanol due to its higher octane number and lower hygroscopicity, which makes it more suitable for application in conventional combustion engines. In S. cerevisiae, the biosynthesis of isobutanol is permitted by the combination of mitochondrial valine synthesis (catalysed by Ilv2, Ilv5 and Ilv3) and its cytosolic degradation (catalysed by Aro10 and Adh2). The different compartmentalisation of the two pathways limit isobutanol biosynthesis. Thus, Brat et al. (2012) were able to increase the isobutanol yield up to 15 mg/gGlc by cytosolic re localisation of the enzymes Ilv2Δ54, Ilv5Δ48 and Ilv3Δ19 (cyt-ILV), with simultaneous deletion of ilv2. This corresponds to approximately 3.7% of the theoretical yield of 410 mg/gGlc, implying existing limitations in isobutanol biosynthesis, which have been investigated in this work.
For yet unknown reasons, isobutanol was only produced by S. cerevisiae in a valine free medium, according to Brat et al. (2012). This work shows that this can be attributed to the catalytic activity of Ilv2Δ54, which acted as growth inhibitor to S. cerevisiae. By this logic, a negative selection on the ILV2∆54 gene was exerted, which made the ilv2 deletion and simultaneous valine exclusion necessary to maintain the functional expression of toxic ILV2∆54. Furthermore, it was shown that valine exclusion is not mandatory due to the feedback regulation of Ilv2, permitted by Ilv6. Rather, increased isobutanol yield was observed when cytosolic Ilv6∆61 was expressed in the valine free medium, which is explained by the enhanced regulation of Ilv2Δ54 by Ilv6∆61 when BCAA are absent. Isobutanol biosynthesis is neither redox nor NAD(P)H co factor balanced. It was seen that co factor imbalance could be mitigated by the expression of an NADH oxidase (NOX), but not by expression of the NADH dependent ilvC6E6, since the latter showed low in vivo activity. Furthermore, it was seen that NAD(H) imbalance did already limit isobutanol biosynthesis, but the NADP(H) imbalance did not. Another limitation of cytosolic isobutanol biosynthesis is the secretion of the intermediate 2‑dihydroxyisovalerate, which then no longer is taken up by S. cerevisiae, causing a reduced isobutanol yield. This is attributed to insufficient Ilv3∆19 activity, due to poor iron sulphur cluster apo protein maturation. Therefore, it was aimed to replace Ilv3∆19 by heterologous dihydroxyacid dehydratases. Even though some of the enzymes were functionally expressed, none showed better in vivo activity than Ilv3∆19. Therefore, the Ilv3∆19 apo protein maturation was improved. This was achieved by the genomic deletion of fra2 or pim1 as well as by the cytosolic expression of Grx5∆29.
In addition to the isobutanol pathway, S. cerevisiae was optimised for isobutanol biosynthesis by rational and evolutionary engineering. For this purpose, the genes which are necessary for isobutanol production were integrated into the ilv2 locus, and the resulting strain was evolved in a medium containing the toxic amino acid analogue norvaline. Evolved single colonies were isolated, which presented improved growth and increased isobutanol yields (0.59 mg/gGlc) in a valine free medium, as compared to the initial strain. This is explained by a gene dosage effect which occurred during the evolutionary engineering experiment. In collaboration with Dr. Wess, the genes ilv2, bdh1/2, leu4/9, ecm31, ilv1, adh1, gpd1/2 and ald6 were cumulatively deleted in CEN.PK113 7D to block competing metabolic pathways. The resulting strain JWY23 achieved isobutanol yields up to 67.3 mg/gGlc, when expressing the cyt ILV enzymes from a multi copy vector. The most promising approaches of this work, namely the deletion of fra2 and the expression of Grx5∆29, Ilv6∆61, and NOX, were confirmed in this JWY23 strain. The highest isobutanol yield from this work was observed at 72 mg/gGlc for Ilv6∆61 and cyt ILV enzymes expressing JWY23, which corresponds to 17.6% of the theoretical isobutanol yield.
Isobutyric acid (IBA) is a by product of isobutanol biosynthesis, but it is also considered a valuable platform chemical. Therefore, the approaches that improved isobutanol biosynthesis were applied to the biosynthesis of IBA in S. cerevisiae. The highest IBA yield of 9.8 mg/gGlc was observed in a valine free medium by expression of cyt ILV enzymes, NOX and Ald6 in JWY04 (CEN.PK113 7D Δilv2; Δbdh1; Δbdh2; Δleu4; Δleu9; Δecm31; Δilv1). This corresponded to an 8.9 fold increase compared with the control and is, to our best knowledge, the highest IBA yield reported to date for S. cerevisiae.
Die Studien im Rahmen dieser Arbeit wurden am Modellorganismus Anabaena sp. PCC 7120 (Anabaena) durchgeführt, einem filamentösen Süßwasser-Cyanobakterium. Cyanobakterien sind photosynthetische, Gram-negative Organismen. Sie besitzen eine das Zytosol begrenzende Plasmamembran und eine Äußere Membran. TonB-abhängige Transporter (TBDTs) und Porine der Äußeren Membran bewerkstelligen und regulieren die Aufnahme von Nährstoffen. Typischerweise wenig abundante Substrate für den TBDT-vermittelten, aktiven Transport sind beispielsweise eisenhaltige Siderophore oder VitaminB12. Kleinere gelöste und abundante Stoffe wie Salze oder andere Ionen gelangen hingegen passiv durch Porine in das Periplasma.
In Anabaena wurden neun putative Porine identifiziert. Sieben hiervon wiesen eine porinspezifische Domänenstruktur auf (Alr0834, Alr2231, All4499, Alr4550, Alr4741, All5191 und All7614), und wurden im Rahmen dieser Arbeit näher betrachtet. Die Expression dieser sieben Gene wurde vergleichend untersucht, nachdem der Wildtyp in Standardmedium oder in Medium indem jeweils Mangan, Eisen, Kupfer oder Zink fehlte angezogen wurde. Außerdem wurde das Wachstum der einzelnen Porinmutanten im Vergleich zum Wildtyp auf Festmedium mit hohen Konzentrationen von Salzen, Antibiotika oder anderen Stoffen analysiert. Hierbei konnten den einzelnen Mutanten teilweise spezifische phänotypische Eigenschaften zugeschrieben werden. Zusammengefasst kann anhand der Analysenergebnisse vermutet werden, dass Alr4550 eine besondere Rolle in der Wahrung der Zellhüllenstabilität oder -integrität spielt, wohingegen das Fehlen von Alr5191 auf unbekannte Weise die Fixierung von Stickstoff zu erschweren scheint. Die alr2231-Mutante zeigte eine Resistenz gegenüber hohen Zinkkonzentrationen, was die Vermutung zulässt, dass Zink ein Substrat von Alr2231 darstellt. Für weitere Porine kann ebenfalls ein Zusammenhang zum Transport von Kupfer oder Mangan vermutet werden.
Neben Porinen wurden ebenfalls TonB-ähnliche Proteine in Anabaena untersucht. TonB ist ein plasmamembranständiges Protein, das in Komplex mit ExbB und ExbD die Energie für Transportprozesse über die Äußere Membran bereitstellt. Hierfür bindet TonB C-terminal an TBDTs und induziert dort Strukturänderungen, welche den Substratimport ins Periplasma ermöglichen. Als Energiequelle wird der Protonengradient genutzt, der über die Plasmamembran besteht. In Anabaena wurden vier putative TonB Proteine identifiziert, die sich jeweils in Länge und Domänenstruktur unterscheiden. Im Rahmen dieser Arbeit konnte durch Substrattransport-Experimente und Wachstumsanalysen gezeigt werden, dass TonB3 an der Aufnahme zweier Siderophore (Schizokinen und dem Xenosiderophor Ferrichrom) beteiligt ist, da die entsprechende Mutante sich als unfähig erwies diese zu als Eisenquelle nutzbar zu machen. Daneben wies TonB3 weitere Merkmale auf, die auch TonB-Proteinen anderer Organismen zugeschrieben wurden (Wachstumsdefizit der Mutante unter Eisenmangel, eisenabhängiges Expressionsprofil). Interessanterweise zeigte sich, dass das Siderophor Ferrichrom ebenfalls nicht als Eisenquelle für die tonB4-Mutante zur Verfügung stand, was zum Beispiel auf eine Beteiligung von TonB4 an dessen Transport hinweisen könnte.
TonB1, welches sich durch ein inkomplettes TBDT-Interaktionsmotiv auszeichnet, und TonB2 konnte keine Beteiligung am Siderophoretransport zugeschrieben werden, jedoch zeigten Mutanten der einzelnen Gene spezifische phänotypische Eigenschaften. Die tonB1-Mutante stach hervor durch ein vergleichsweise stark verzögertes Wachstum unter diazotrophen Bedingungen. Es konnte gezeigt werden, dass sowohl die Nitrogenaseaktivität als auch die expression vermindert war im tonB1-Mutantenstamm. Außerdem zeigten die Heterozysten dieser Mutante, die auf die Stickstoffixierung spezialisierten Zellen, eine abnormale Morphologie. Da die Expression von tonB1 jedoch nach dem Überführen von Wildypzellen in stickstoffreies Medium nicht erhöht war, kann eine direkte Beteiligung von TonB1 an der Heterozystendifferenzierung als unwahrscheinlich betrachtet werden. Die Zelleinschnürungen zwischen Heterozysten und vegetativen Zellen waren in I-tonB1 weniger ausgeprägt als im Wildtyp, was durch eine Anfärbung der Zellwand mit einem Fluoreszenzmarker gezeigt werden konnte. Ebenfalls konnte anhand des fluoreszierenden Markers Calcein gezeigt werden, dass die molekulare Diffusionsgeschwindigkeit zwischen Heterozysten und vegetativen Zellen, und auch zwischen zwei benachbarten vegetativen Zellen, in der tonB1-Mutante erhöht ist. Deswegen kann hier vermutlich vermehrt die Nitrogenase schädigender Sauerstoff in Heterozysten eindringen. Die aufgezählten Ergebnisse deuten auf eine Funktion von SjdR im Aufbau der Septumsstrukturen hin, beispielsweise durch Regulation der Peptidoglykansynthese oder -verteilung, weswegen TonB1 umbenannt wurde in SjdR (Septal junction disc regulator).
Die Untersuchung der tonB2-Mutante zeigte bei dieser eine veränderte Pigmentierung, eine vermehrte Lipopolysaccharidproduktion und Filamentaggregation sowie eine erhöhte Resistenz gegenüber bestimmten Antibiotika oder Detergenzien. Letzteres könnte auf die ebenfalls in der tonB2-Mutante beobachtete verringerte Porinexpression zurückgeführt werden. Es wurde außerdem eine vermehrte Anreicherung von Kupfer und Molybdän in der Mutante gemessen, was ein Grund für die Veränderte Pigmentierung sein könnte und ebenfalls die Porinexpression beeinflussen könnte. Insgesamt scheint sich das Fehlen von TonB2 auf die Integrität der Äußeren Membran auszuwirken. Daher kann für TonB2, eine Funktion in Anlehnung an das Tol-system vermutet werden.
In recent years, several neuronal differentiation protocols were published that circumvent the requirement of embryoid body (EB) formation under serum-deprivation and simplified medium conditions. But a neuronal default model to establish an approach that works efficiently for all pluripotent cells and neuronal precursors is still lacking. Whether such a default neural mechanism exist and how this is implemented across a broad spectrum of cell source, is addressed in several studies and still controversially discussed. It was proposed that the default neuronal fate is initiated in the absence of extrinsic signals and is achieved by eliminating extracellular inhibitors of neuroectodermal fate and suppressing cell-cell signalling through limited cell density. Previous studies reported that ESC and ECC grown at low density and in absence of exogenous factors or feeder layers die within 24 h but acquire a neural identity as indicated by expression of the neural marker Nestin. Thus, this application is not suitable for generating neural cultures. Furthermore, it was reported that P19 cells survive and express neuroectodermal marker genes in serum-free DMEM/F12 medium containing transferrin, insulin, and selenite, although no neurites were identified.
Based on this background, in this study, a novel approach to induce neuronal differentiation in vitro was developed that implements a nutrient-poor environment, which, in contrast to previous studies, ensures the survival of neuronally differentiated cells over a long period of time and allows normal formation of neurites. Neither the formation of free-floating aggregates nor supplementation of growth factors or known inducers was required to establish a reliable neuronal differentiation protocol. A simple medium, consisting of DMEM/F12+N2 that was highly diluted in salt solution, was sufficient to drive a fast neuronal differentiation in monolayer cultures. Serum deprivation and strong dilution of DMEM/F12+N2 medium cause a nutrient-poor environment in which the influence of growth factors and inducers is minimized. This medium creates a metabolically defined environment that is presumably free of extrinsic signals that prevent the decision of neuronal fate. Analysis of the medium components discovered no actual inducer. Hence, it was suggested that the metabolic composition of the medium exclusively covers specific cell requirements of neurons, therefore ensures their survival, and drives the switch from pluripotent cells to neurons. The self-developed method was established by usage of the murine embryonal carcinoma cell line P19 and could be transferred to murine ESC. Consequently, the method could provide a feasible protocol for a generally valid neuronal default model.
The established protocol provides several advantages such as the possibility to generate stable pure neuronal cultures by a fast, simple, and highly reproducible one-step induction under defined medium conditions with a minimum of exogen effectors. The method is characterised by clear and steady medium conditions that makes the investigation of specific cell requirements during differentiation accessible. It is therefore expected to be a useful tool to investigate the molecular basis of neuronal differentiation as well as for high throughput screenings. The phenotype of mature postmitotic neurons was arising within one week and cultures were shown to stay stable at least for three weeks. The neuronal identity was confirmed by expression of neuronal markers through immunofluorescence staining and mass spectrometry analysis. Furthermore, increased levels of axon markers were detected in early neuronal differentiation and functionality of the synapses of the P19-derived neurons was ascertained by detection of calcium activity. Axonal laser ablation, immediately followed by fast regrowth of connections in the neuronal network, revealed a strong regeneration potential under the given conditions. Furthermore, the generated neurons showed a morphologically distinct phenotype and the formation of neural rosettes. Immunofluorescence staining demonstrated the generation of pure and homogeneous neuronal cultures, free of glial cells.
Retinoic acid (RA) plays an essential role in cell signalling during embryogenesis and efficiently induces neuronal differentiation in vitro in a concentration dependent manner. Neither retinol nor retinoic acid was included in any of the components of the self-prepared medium in this work. However, I observed, dependence on RARβ- and/or RARγ-regulated RA signalling in serum-free monolayer cultures. Nevertheless, neuronal differentiation in serum-free monolayer cultures was assumed to be RARα-independent because (i) RARα was slightly downregulated after neuronal induction, (ii) the truncated RARα of the RAC65 mutant had no effect on induction efficiency, and (iii) a pan-RAR inhibitor suppressed neuronal differentiation. In contrast to serum-free monolayer cultures, the truncated RARα prevented neuronal differentiation by application of the conventional protocol where cells are grown in free floating cell aggregates in serum-containing medium. Proteome analysis of P19 cells, treated by the self-developed differentiation protocol over five days showed increased levels of cellular RA binding proteins that mediate the cellular RA transport and are involved in canonical as well as non-canonical RA signalling.
...